|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
Highlights include the best six month survival documented in a LVAD CE Mark clinical study and low rates of adverse events with zero pump thrombosis events
Letter sent to remind hospitals to check backup battery expiration for "Pocket" System Controllers™ used with the HeartMate II® Left Ventricular Assist System (LVAS)
The cardiac device company's shares dipped more than 20% on news of the transaction, which could be worth up to $860 million.
Trade-Ideas LLC identified Thoratec (THOR) as a pre-market mover with heavy volume candidate
With Thoratec Corp. (THOR) off the market following its recent purchase by St. Jude Medical Inc. (STJ), M&A activity may start to circulate in the heart care device sector.
Last year was big for medical device mergers and things could be heating up again this year.
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Thoratec Corp.
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased or otherwise acquired Thoratec Corp.
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Thoratec...
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Thoratec Corp.
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Thoratec Corporation ("Thoratec" or the "Company") (NASDAQ:THOR) concerning the proposed acquisition of the Company by St.
Apple's tumble pressured markets on Wednesday, punishing benchmark indexes in a post-earnings slump.
Stocks remain in the red on Wednesday as crude oil closes below $50, its lowest level since April 2.
The Rosen Law Firm, a global investor rights law firm, announces that it is investigating the Board of Directors of Thoratec Corp.
Microsoft (MSFT) shares fell after revenue projections came in weaker than expected.